Home LiteratureArticle Details
PMID: 18509334 Published · ppublish English Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Dissecting direct reprogramming through integrative genomic analysis.

Nature ·Vol. 454 ·No. 7200 ·2008-07-03 ·Pages 49-55

Mikkelsen TS, Hanna J, Zhang X, Ku M, Wernig M, Schorderet P, Bernstein BE, Jaenisch R, Lander ES, Meissner A

Abstract

Somatic cells can be reprogrammed to a pluripotent state through the ectopic expression of defined transcription factors. Understanding the mechanism and kinetics of this transformation may shed light on the nature of developmental potency and suggest strategies with improved efficiency or safety. Here we report an integrative genomic analysis of reprogramming of mouse fibroblasts and B lymphocytes. Lineage-committed cells show a complex response to the ectopic expression involving induction of genes downstream of individual reprogramming factors. Fully reprogrammed cells show gene expression and epigenetic states that are highly similar to embryonic stem cells. In contrast, stable partially reprogrammed cell lines show reactivation of a distinctive subset of stem-cell-related genes, incomplete repression of lineage-specifying transcription factors, and DNA hypermethylation at pluripotency-related loci. These observations suggest that some cells may become trapped in partially reprogrammed states owing to incomplete repression of transcription factors, and that DNA de-methylation is an inefficient step in the transition to pluripotency. We demonstrate that RNA inhibition of transcription factors can facilitate reprogramming, and that treatment with DNA methyltransferase inhibitors can improve the overall efficiency of the reprogramming process.

MeSH Terms
Animals Azacitidine/pharmacology Cell Line Cell Lineage Cellular Reprogramming/genetics Chromatin/metabolism DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases/antagonists & inhibitors,genetics,metabolism DNA Methylation Embryonic Stem Cells/metabolism Enzyme Inhibitors/pharmacology Gene Expression Profiling Gene Expression Regulation, Developmental Genome/genetics Genomics Mice Pluripotent Stem Cells/cytology,metabolism Transcription Factors/deficiency,genetics
Chemicals
Chromatin Enzyme Inhibitors Transcription Factors DNA (Cytosine-5-)-Methyltransferase 1 DNA (Cytosine-5-)-Methyltransferases Azacitidine
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Mikkelsen Tarjei S
Broad Institute of MIT and Harvard, 7 Cambridge Center, Cambridge, Massachusetts 02142, USA.
Hanna Jacob
Zhang Xiaolan
Ku Manching
Wernig Marius
Schorderet Patrick
Bernstein Bradley E
Jaenisch Rudolf
Lander Eric S
Meissner Alexander
References (33)
33 references, click to expand
  1. Generation of germline-competent induced pluripotent stem cells.
    Nature. 2007 Jul 19;448(7151):313-7 PMID: 17554338
  2. A heterogeneous expression pattern for Nanog in embryonic stem cells.
    Stem Cells. 2007 Oct;25(10):2534-42 PMID: 17615266
  3. Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming.
    Cell. 2008 Feb 22;132(4):567-82 PMID: 18295576
  4. Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells.
    Genesis. 2006 Jan;44(1):23-8 PMID: 16400644
  5. Genome-scale DNA methylation maps of pluripotent and differentiated cells.
    Nature. 2008 Aug 7;454(7205):766-70 PMID: 18600261
  6. Generation of human induced pluripotent stem cells from dermal fibroblasts.
    Proc Natl Acad Sci U S A. 2008 Feb 26;105(8):2883-8 PMID: 18287077
  7. Capturing pluripotency.
    Cell. 2008 Feb 22;132(4):532-6 PMID: 18295569
  8. Zic3 is required for maintenance of pluripotency in embryonic stem cells.
    Mol Biol Cell. 2007 Apr;18(4):1348-58 PMID: 17267691
  9. The ARF tumor suppressor: keeping Myc on a leash.
    Cell Cycle. 2005 Feb;4(2):249-52 PMID: 15655352
  10. Reduced representation bisulfite sequencing for comparative high-resolution DNA methylation analysis.
    Nucleic Acids Res. 2005 Oct 13;33(18):5868-77 PMID: 16224102
  11. The mammalian epigenome.
    Cell. 2007 Feb 23;128(4):669-81 PMID: 17320505
  12. Loss of genomic methylation causes p53-dependent apoptosis and epigenetic deregulation.
    Nat Genet. 2001 Jan;27(1):31-9 PMID: 11137995
  13. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells.
    Development. 1996 Oct;122(10):3195-205 PMID: 8898232
  14. Induced pluripotent stem cell lines derived from human somatic cells.
    Science. 2007 Dec 21;318(5858):1917-20 PMID: 18029452
  15. Reprogramming of human somatic cells to pluripotency with defined factors.
    Nature. 2008 Jan 10;451(7175):141-6 PMID: 18157115
  16. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors.
    Cell. 2006 Aug 25;126(4):663-76 PMID: 16904174
  17. Direct reprogramming of genetically unmodified fibroblasts into pluripotent stem cells.
    Nat Biotechnol. 2007 Oct;25(10):1177-81 PMID: 17724450
  18. Transcriptional repression and DNA hypermethylation of a small set of ES cell marker genes in male germline stem cells.
    BMC Dev Biol. 2006 Jul 21;6:34 PMID: 16859545
  19. Directly reprogrammed fibroblasts show global epigenetic remodeling and widespread tissue contribution.
    Cell Stem Cell. 2007 Jun 7;1(1):55-70 PMID: 18371336
  20. Generation of induced pluripotent stem cells without Myc from mouse and human fibroblasts.
    Nat Biotechnol. 2008 Jan;26(1):101-6 PMID: 18059259
  21. Deconstructing stem cell self-renewal: genetic insights into cell-cycle regulation.
    Nat Rev Genet. 2008 Feb;9(2):115-28 PMID: 18202695
  22. In vitro reprogramming of fibroblasts into a pluripotent ES-cell-like state.
    Nature. 2007 Jul 19;448(7151):318-24 PMID: 17554336
  23. KLF4, p21 and context-dependent opposing forces in cancer.
    Nat Rev Cancer. 2006 Jan;6(1):11-23 PMID: 16372018
  24. Genome-wide maps of chromatin state in pluripotent and lineage-committed cells.
    Nature. 2007 Aug 2;448(7153):553-60 PMID: 17603471
  25. Defining molecular cornerstones during fibroblast to iPS cell reprogramming in mouse.
    Cell Stem Cell. 2008 Mar 6;2(3):230-40 PMID: 18371448
  26. Strategies and new developments in the generation of patient-specific pluripotent stem cells.
    Cell Stem Cell. 2007 Jun 7;1(1):39-49 PMID: 18371333
  27. Generation of pluripotent stem cells from adult mouse liver and stomach cells.
    Science. 2008 Aug 1;321(5889):699-702 PMID: 18276851
  28. Sequential expression of pluripotency markers during direct reprogramming of mouse somatic cells.
    Cell Stem Cell. 2008 Feb 7;2(2):151-9 PMID: 18371436
  29. Transcriptional regulation and transformation by Myc proteins.
    Nat Rev Mol Cell Biol. 2005 Aug;6(8):635-45 PMID: 16064138
  30. Generation of mice from wild-type and targeted ES cells by nuclear cloning.
    Nat Genet. 2000 Feb;24(2):109-10 PMID: 10655052
  31. Chromatin dynamics during epigenetic reprogramming in the mouse germ line.
    Nature. 2008 Apr 17;452(7189):877-81 PMID: 18354397
  32. Direct reprogramming of terminally differentiated mature B lymphocytes to pluripotency.
    Cell. 2008 Apr 18;133(2):250-64 PMID: 18423197
  33. Induction of pluripotent stem cells from adult human fibroblasts by defined factors.
    Cell. 2007 Nov 30;131(5):861-72 PMID: 18035408
Article Info
Journal
Nature
Abbr.
Nature
ISSN
1476-4687
Published
2008-07-03
Epub
2008-00-28
Pages
49-55
Language
English
Region
England
NLM ID
0410462
PMCID
PMC2754827
Subset
IM
Grants
NHGRI NIH HHS · U54 HG003067 · United States
NHGRI NIH HHS · U54 HG003067-04 · United States
Databases
Corrections
ErratumIn
-
CommentIn
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com